Can a mobile BiPAP device reduce dyspnea when climbing stairs in patients with moderate to severe COPD? - A randomized crossover study -

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00017613

Enrollment

Registered

2019-07-08

Start date

2019-09-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J44.8

Interventions

Group 1: First stair climbing test (2 flights of stairs, 43 steps) with mobile BiPAP device (Vita Breath, Philips) and second stair climbing test(2 flights of stairs, 43 steps) without the mobile BiPA

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - COPD stages III and IV - Definition on the basis of the GOLD Guideline - Exclusion of acute exacerbation - Signed consent form - Patient age = 18 years

Exclusion criteria

Exclusion criteria: - Patient age < 18 years - Mental retardation - Missing declaration of consent - Acute exacerbation of the disease - gait uncertainty

Design outcomes

Primary

Measure	Time frame
Mean difference of the Borg dyspnoea scale before and after completion of the stair climbing test with and without use of the mobile BiPAP device "VitaBreath".	—

Secondary

Measure	Time frame
- Results of blood gas analysis after climbing stairs - Time until the specified number of stairs is reached - Results of the SPO2 measurement before and after exercise	—

Countries

Germany

Contacts

Public ContactWolfram Windisch

Kliniken der Stadt Köln gGmbHLehrstuhl für PneumologieUniversität Witten/Herdecke

windischw@kliniken-koeln.de0221890718929

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026